Genomic scan of 254 hereditary prostate cancer families

被引:47
作者
Janer, M
Friedrichsen, DM
Stanford, JL
Badzioch, MD
Kolb, S
Deutsch, K
Peters, MA
Goode, EL
Welti, R
DeFrance, HB
Iwasaki, L
Li, S
Hood, L
Ostrander, EA
Jarvik, GP
机构
[1] Univ Washington, Med Ctr, Div Med Genet, Dept Med, Seattle, WA 98195 USA
[2] Inst Syst Biol, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[5] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[6] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[7] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
关键词
prostate cancer; ovarian cancer; brain cancer; genetic susceptibility; heterogeneity; linkage analysis;
D O I
10.1002/pros.10305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary prostate cancer (HPC) is a genetically heterogeneous disease, complicating efforts to map and clone susceptibility loci. We have used stratification of a large dataset of 254 HPC families in an effort to improve power to detect HPC loci and to understand what types of family features may improve locus identification. The strongest result is that of a dominant locus at 6p22.3 (heterogeneity LOD (HLOD) = 2.51), the evidence for which is increased by consideration of the age of PC onset (HLOD = 3.43 in 214 families with median age-of-onset 56-72 years) and co-occurrence of primary brain cancer (HLOD = 2.34 in 21 families) in the families. Additional regions for which we observe modest evidence for linkage include chromosome 7q and 17p. Only weak evidence of several previously implicated HPC regions is detected. These analyses support the existence of multiple HPC loci, whose presence may be best identified by analyses of large, including pooled, datasets which consider locus heterogeneity.
引用
收藏
页码:309 / 319
页数:11
相关论文
共 80 条
[51]  
Macklin M.T., 1954, P 2 NATL CANC C, P1074
[52]   BRCA1 mutations and breast cancer in the general population -: Analyses in women before age 35 years and in women before age 45 years with first-degree family history [J].
Malone, KE ;
Daling, JR ;
Thompson, JD ;
O'Brien, CA ;
Francisco, LV ;
Ostrander, EA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :922-929
[53]   Efficient multipoint linkage analysis through reduction of inheritance space [J].
Markianos, K ;
Daly, MJ ;
Kruglyak, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (04) :963-977
[54]   Linkage analysis of 49 high-risk families does not support a common familial prostate cancer susceptibility gene at 1q24-25 [J].
McIndoe, RA ;
Stanford, JL ;
Gibbs, M ;
Jarvik, GP ;
Brandzel, S ;
Neal, CL ;
Li, S ;
Gammack, JT ;
Gay, AA ;
Goode, EL ;
Hood, L ;
Ostrander, EA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :347-353
[55]   EVIDENCE OF AN X-LINKED OR RECESSIVE GENETIC COMPONENT TO PROSTATE-CANCER RISK [J].
MONROE, KR ;
YU, MC ;
KOLONEL, LN ;
COETZEE, GA ;
WILKENS, LR ;
ROSS, RK ;
HENDERSON, BE .
NATURE MEDICINE, 1995, 1 (08) :827-829
[56]  
MORGANTI G, 1956, Acta Genet Stat Med, V6, P304
[57]   THE IMPACT OF FAMILY HISTORY ON EARLY DETECTION OF PROSTATE-CANCER [J].
NAROD, SA ;
DUPONT, A ;
CUSAN, L ;
DIAMOND, P ;
GOMEZ, JL ;
SUBURU, R ;
LABRIE, F .
NATURE MEDICINE, 1995, 1 (02) :99-101
[58]   PedCheck: A program for identification of genotype incompatibilities in linkage analysis [J].
O'Connell, JR ;
Weeks, DE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :259-266
[59]  
OTT J, 1986, GENET EPIDEMIOL, P251
[60]  
Page WF, 1997, PROSTATE, V33, P240